Breaking News

Cellectricon Launches Discovery Services

Cytoskeletal offerings aim to shorten development times

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cellectricon, a provider of advanced cell-based screening technologies, has launched its Discovery Services division. The new services offer phenotypic screening support to pharma/biotech companies and CROs, aimed at accelerating drug discovery and cell-based assay research into cytoskeletal disturbances, especially for chronic pain.   Cellectricon’s Discovery Services aim to shorten lead development times and reduce costs with expertise in assay development and screening. Cellectricon&#82...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters